- Investing Ideas
- /
- Swedish Biotech Stocks
Swedish Biotech Stocks
Results
49
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
49 companies
Sprint Bioscience
Market Cap: SEK 61.4m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.58
7D
-1.0%
1Y
-53.2%
Inhalation Sciences Sweden
Market Cap: SEK 65.8m
Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.
ISAB
SEK 4.34
7D
0%
1Y
24.4%
Genetic Analysis
Market Cap: NOK 60.8m
A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.
GEAN
NOK 0.88
7D
-15.4%
1Y
31.3%
ExpreS2ion Biotech Holding
Market Cap: SEK 44.8m
A biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally.
EXPRS2
SEK 16.86
7D
-2.1%
1Y
-58.3%
Novakand Pharma
Market Cap: SEK 32.5m
Kancera AB (publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally.
KAN
SEK 0.27
7D
-71.1%
1Y
-86.8%
Chosa Oncology
Market Cap: SEK 34.4m
Develops oncology drugs for the treatment of cancer.
CHOSA
SEK 0.53
7D
0%
1Y
-59.2%
Aptahem
Market Cap: SEK 26.8m
A biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.
APTA
SEK 1.56
7D
12.3%
1Y
-64.5%
Spermosens
Market Cap: SEK 24.1m
Provides diagnostic health care products and services in Sweden.
SPERM
SEK 0.0076
7D
0%
1Y
-65.1%
Level Bio
Market Cap: SEK 22.6m
Manufactures and distributes cutting-edge solutions in the Nordic region and internationally.
LEVBIO
SEK 0.32
7D
-1.8%
1Y
11.0%
Stayble Therapeutics
Market Cap: SEK 15.4m
Develops injectable treatment for chronic pain triggered by disc degeneration.
STABL
SEK 0.24
7D
-19.1%
1Y
-61.6%
Diagonal Bio
Market Cap: SEK 14.8m
Operates as a biotechnology company in Sweden.
DIABIO
SEK 0.008
7D
0%
1Y
-7.0%
Double Bond Pharmaceutical International
Market Cap: SEK 12.9m
A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.
DBP B
SEK 0.12
7D
9.1%
1Y
-72.7%
DanCann Pharma
Market Cap: DKK 2.5m
A biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas.
DANCAN
DKK 0.62
7D
-12.7%
1Y
-89.3%